Volume 86, Issue 4, Pages (October 2014)

Slides:



Advertisements
Similar presentations
Figure Legend: From: Perioperative Organ Injury
Advertisements

Pathological roles of purinergic signaling in the liver
Pathways of liver injury in alcoholic liver disease
Volume 68, Issue 6, Pages (December 2005)
The Th17 immune response in renal inflammation
Nat. Rev. Nephrol. doi: /nrneph
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
EGFR signaling in renal fibrosis
Volume 93, Issue 1, Pages (January 2018)
JAK/STAT signaling in renal diseases
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
The impact of cold ischemia time on renal transplant outcome
Volume 81, Issue 3, Pages (February 2012)
Pathways of liver injury in alcoholic liver disease
Volume 73, Issue 9, Pages (May 2008)
Infection and chronic allograft dysfunction
Programmed anti-inflammatory macrophages protect against AKI and promote repair through trophic actions  Christof Westenfelder  Kidney International 
Volume 68, Issue 6, Pages (December 2005)
Volume 70, Issue 7, Pages (October 2006)
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
Cees G.M. Kallenberg, Peter Heeringa  Kidney International 
Volume 80, Issue 8, Pages (October 2011)
Igor Łoniewski, Donald E. Wesson  Kidney International 
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Osteopontin in diabetic nephropathy: signpost or road?
Qingqing Wei, Zheng Dong  Kidney International 
Churg–Strauss syndrome
Macrophages and hypoxia in human chronic kidney disease
Volume 83, Issue 4, Pages (April 2013)
Volume 72, Issue 2, Pages (July 2007)
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Adenosine A2A agonists as therapy for glomerulonephritis
Calcium sensing in podocytes
Twist: a new link from hypoxia to fibrosis
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Volume 56, Issue 4, Pages (October 1999)
CD4+ T cells: a potential player in renal fibrosis
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Tubulointerstitial damage and progression of renal failure
Circadian regulation of renal function
New paradigms in cell death in human diabetic nephropathy
Volume 82, Issue 9, Pages (November 2012)
Basophils and mast cells in renal injury
The treatment of acute interstitial nephritis: More data at last
Volume 69, Issue 11, Pages (June 2006)
Paola Romagnani, Hans-Joachim Anders  Kidney International 
Volume 71, Issue 12, Pages (June 2007)
NODding off in acute kidney injury with progranulin?
Stephen O'Neill, Jeremy Hughes  Kidney International 
Nanocrystals seed calcification in more ways than one
Does equal care give equal outcomes?
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 69, Issue 5, Pages (March 2006)
Overview of the cellular and molecular basis of kidney fibrosis
Volume 80, Issue 10, Pages (November 2011)
Is complement a target for therapy in renal disease?
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 70, Issue 2, Pages (July 2006)
Volume 75, Issue 6, Pages (March 2009)
T cells and T-cell receptors in acute renal failure
B cells and tertiary lymphoid organs in renal inflammation
A Metabolic Roadblock in Inflammatory Macrophages
Volume 72, Issue 8, Pages (October 2007)
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Something in the Air: Hyperoxic Conditioning of the Tumor Microenvironment for Enhanced Immunotherapy  Robert D. Leone, Maureen R. Horton, Jonathan D.
Presentation transcript:

Volume 86, Issue 4, Pages 685-692 (October 2014) The role of adenosine receptors A2A and A2B signaling in renal fibrosis  Veena S. Roberts, Peter J. Cowan, Stephen I. Alexander, Simon C. Robson, Karen M. Dwyer  Kidney International  Volume 86, Issue 4, Pages 685-692 (October 2014) DOI: 10.1038/ki.2014.244 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Extracellular purinergic catabolic and signaling pathways. Kidney International 2014 86, 685-692DOI: (10.1038/ki.2014.244) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Adenosine inhibits the expression of pro-inflammatory cytokines by M1 macrophages via A2AR signaling, and promotes a shift to the anti-inflammatory M2 phenotype via A2BR signaling. Kidney International 2014 86, 685-692DOI: (10.1038/ki.2014.244) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Adenosine signaling via A2AR and A2BR reduces inflammation. (Left panel) Renal injury promotes macrophage and T effector cell infiltration that is associated with increased inflammation and renal fibrosis. Cellular damage releases adenosine triphosphate (ATP), which is hydrolyzed to adenosine by extracellular CD39 and CD73. Equilibrative nucleoside transporter (ENT) removes adenosine from the extracellular space into the intracellular space and is distributed on the blood vessels and tubular cells. (Right panel) Adenosine signaling via A2AR and A2BR reduces infiltration of T-effector and M1 macrophages and promotes generation of regulatory T cells and M2 macrophages, which are associated with reduced inflammation and less fibrosis. Kidney International 2014 86, 685-692DOI: (10.1038/ki.2014.244) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Experimental models of hypertension and diabetes reveal increased adenosine generation and A2BR expression. A2BR activation on fibroblasts and mesangial cells promotes extracellular matrix deposition driving the development of renal fibrosis. Vasoconstriction mediated by endothelin-1 promotes hypoxia which is perpetuated by renal fibrosis. Chronic hypoxia further drives adenosine generation and A2BR activity, creating a vicious cycle of chronic hypoxia and renal fibrosis. Kidney International 2014 86, 685-692DOI: (10.1038/ki.2014.244) Copyright © 2014 International Society of Nephrology Terms and Conditions